Casocot, Nerie N.

HRN: 10-67-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/26/2023
08/31/2023
IV
500MG
Q8
Intraabdominal Infection
Waiting Final Action 
08/27/2023
METRONIDAZOLE 500MG (TAB)
08/27/2023
09/03/2023
PO
1 Tab
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: